Federation Des Caisses Desjardins Du Quebec Aditxt, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 14, 2024
SELL
$0.14 - $135.6 $350 - $339,000
-2,500 Closed
0 $0
Q2 2022

Aug 14, 2024
SELL
$0.13 - $0.46 $260 - $920
-2,000 Reduced 44.44%
2,500 $358,000
Q1 2022

Aug 14, 2024
BUY
$0.34 - $0.58 $1,530 - $2,610
4,500 New
4,500 $2.06 Million
Q4 2021

Aug 30, 2024
BUY
$0.54 - $2.51 $2,160 - $10,040
4,000 Added 800.0%
4,500 $2.41 Million
Q2 2021

Aug 30, 2024
BUY
$2.2 - $3.2 $1,100 - $1,600
500 New
500 $1.3 Million
Q1 2021

Aug 30, 2024
BUY
$2.08 - $5.26 $1,040 - $2,630
500 New
500 $1.28 Million

About Aditxt, Inc.

ADTX Quotes by TradingView
  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $1.41M
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email